Ulta Beauty is on the brink of releasing its third-quarter financial results, and the investment community is abuzz with anticipation. This period has seen key analysts refining their predictions for the beauty retailer's performance. The company's recent appointment of a new Chief Financial Officer also adds another layer of interest to its upcoming report. Investors and market watchers are closely scrutinizing these forecasts to gauge the potential direction of Ulta's stock.
Detailed Financial and Analyst Insights for Ulta Beauty
On December 4, Ulta Beauty, Inc. is scheduled to unveil its third-quarter earnings report following the market's close. Analysts are collectively forecasting that the Bolingbrook, Illinois-headquartered enterprise will declare earnings per share of $4.60, marking a decrease from $5.14 recorded in the corresponding period of the previous year. However, there's a brighter outlook for revenue, with consensus estimates pointing towards $2.7 billion, an increase from $2.53 billion in the prior year's third quarter.
Adding a notable development to the company's recent activities, Ulta Beauty announced the appointment of Christopher DelOrefice as its new Chief Financial Officer on October 16. This leadership change comes as the company navigates a dynamic market landscape.
Ahead of the earnings announcement, several prominent analysts have updated their ratings and price targets for Ulta Beauty shares:
- JP Morgan's Christopher Horvers reaffirmed an Overweight rating and modestly elevated the price target from $600 to $606 on December 1, 2025, reflecting a 74% accuracy rate.
- Telsey Advisory Group's Dana Telsey maintained an Outperform rating with a consistent price target of $610, also on December 1, 2025, showcasing a 63% accuracy rate.
- Wells Fargo's Ike Boruchow upheld an Underweight rating but adjusted the price target upwards from $425 to $450 on October 16, 2025, with an accuracy rate of 71%.
- Canaccord Genuity's Susan Anderson kept a Buy rating and increased the price target from $650 to $653 on October 10, 2025, holding a 61% accuracy rate.
- Barclays' Adrienne Yih reiterated an Overweight rating and raised the price target from $589 to $617 on September 2, 2025, demonstrating a 68% accuracy rate.
The company's stock experienced a slight dip, closing at $544.52 on Wednesday, a 0.6% reduction. These analyst revisions offer a critical perspective for potential investors as Ulta Beauty approaches its financial disclosure.
This upcoming earnings call will be crucial for Ulta Beauty, providing clarity on its financial health and future trajectory. The varying analyst perspectives highlight the complexities of assessing market performance, underscoring the importance of diverse expert opinions in making informed investment choices.